Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT01140204
Eligibility Criteria:
Inclusion Criteria:
* male and postmenopausal female patients
* aged 18 years and older
* clinical evidence of stable or unstable angina, a positive functional test and a stentable de novo lesion in a native coronary artery
* diameter stenosis \> 70% (visual estimate), lesion length \< 25 mm, and a vessel diameter ≥ 2.5 mm.
Exclusion Criteria:
* acute myocardial infarction
* left ventricular ejection fraction of \< 30%
* aorto-ostial lesion
* unprotected left main lesion or a bypass graft
* clear angiographic calcification in the target lesion
* visible thrombus proximal to the lesion
* chronic total occlusion
* platelet count \<100,000 cells/mm3 or \>700,000 cells/mm3
* WBC \<3,000 cells/mm3
* known hypersensitivity or contraindication to aspirin, heparin, clopidogrel, abciximab, paclitaxel, stainless steel
* sensitivity to contrast media not amenable to adequate premedication
* medical illness (i.e. cancer, liver disease or congestive heart failure) associated with a life expectancy of less than two years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01140204
Study Brief:
Protocol Section:
NCT01140204